{"id":"https://openalex.org/W1964396296","doi":"https://doi.org/10.1097/00004850-199409000-00005","title":"The effects of administration of mCPP on psychological, cognitive, cardiovascular, hormonal and MHPG measurements in human volunteers","display_name":"The effects of administration of mCPP on psychological, cognitive, cardiovascular, hormonal and MHPG measurements in human volunteers","alternate_titles":[],"publication_year":1994,"publication_date":"1994-09-01","ids":{"openalex":"https://openalex.org/W1964396296","doi":"https://doi.org/10.1097/00004850-199409000-00005","mag":"1964396296","pmid":"https://pubmed.ncbi.nlm.nih.gov/7814826"},"language":"en","primary_location":{"id":"doi:10.1097/00004850-199409000-00005","doi":"https://doi.org/10.1097/00004850-199409000-00005","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004850-199409000-00005","pdf_url":null,"source":{"id":"https://openalex.org/S149156103","display_name":"International Clinical Psychopharmacology","issn_l":"0268-1315","issn":["0268-1315","1473-5857"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Clinical Psychopharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1964396296"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5104688337","display_name":"Peter H. Silverstone","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},{"id":"https://openalex.org/I4210157844","display_name":"Littlemore Hospital","ror":"https://ror.org/03exj3651","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210157844"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"P. H. Silverstone","raw_affiliation_strings":["MRC Unit of Clinical Pharmacology, Littlemore Hospital, Oxford, UK","MRC Unit of Clinical Pharmacology and University Department of Psychiatry, Littlemore Hospital, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MRC Unit of Clinical Pharmacology, Littlemore Hospital, Oxford, UK","institution_ids":["https://openalex.org/I4210157844"]},{"raw_affiliation_string":"MRC Unit of Clinical Pharmacology and University Department of Psychiatry, Littlemore Hospital, Oxford, UK","institution_ids":["https://openalex.org/I40120149","https://openalex.org/I4210157844"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032704269","display_name":"Judith E. Rue","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},{"id":"https://openalex.org/I4210157844","display_name":"Littlemore Hospital","ror":"https://ror.org/03exj3651","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210157844"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J. E. Rue","raw_affiliation_strings":["MRC Unit of Clinical Pharmacology and University Department of Psychiatry, Littlemore Hospital, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MRC Unit of Clinical Pharmacology and University Department of Psychiatry, Littlemore Hospital, Oxford, UK","institution_ids":["https://openalex.org/I40120149","https://openalex.org/I4210157844"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111129388","display_name":"M. Franklin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},{"id":"https://openalex.org/I4210157844","display_name":"Littlemore Hospital","ror":"https://ror.org/03exj3651","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210157844"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M. Franklin","raw_affiliation_strings":["MRC Unit of Clinical Pharmacology and University Department of Psychiatry, Littlemore Hospital, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MRC Unit of Clinical Pharmacology and University Department of Psychiatry, Littlemore Hospital, Oxford, UK","institution_ids":["https://openalex.org/I40120149","https://openalex.org/I4210157844"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113772254","display_name":"K F Hallis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},{"id":"https://openalex.org/I4210157844","display_name":"Littlemore Hospital","ror":"https://ror.org/03exj3651","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210157844"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"K. Hallis","raw_affiliation_strings":["MRC Unit of Clinical Pharmacology and University Department of Psychiatry, Littlemore Hospital, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MRC Unit of Clinical Pharmacology and University Department of Psychiatry, Littlemore Hospital, Oxford, UK","institution_ids":["https://openalex.org/I40120149","https://openalex.org/I4210157844"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019422924","display_name":"G. Camplin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},{"id":"https://openalex.org/I4210157844","display_name":"Littlemore Hospital","ror":"https://ror.org/03exj3651","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210157844"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"G. Camplin","raw_affiliation_strings":["MRC Unit of Clinical Pharmacology and University Department of Psychiatry, Littlemore Hospital, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MRC Unit of Clinical Pharmacology and University Department of Psychiatry, Littlemore Hospital, Oxford, UK","institution_ids":["https://openalex.org/I40120149","https://openalex.org/I4210157844"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057572189","display_name":"D.A. Laver","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},{"id":"https://openalex.org/I4210157844","display_name":"Littlemore Hospital","ror":"https://ror.org/03exj3651","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210157844"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"D. Laver","raw_affiliation_strings":["MRC Unit of Clinical Pharmacology and University Department of Psychiatry, Littlemore Hospital, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MRC Unit of Clinical Pharmacology and University Department of Psychiatry, Littlemore Hospital, Oxford, UK","institution_ids":["https://openalex.org/I40120149","https://openalex.org/I4210157844"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5023209431","display_name":"Philip J. Cowen","orcid":"https://orcid.org/0000-0001-5518-6138","observed_orcids":["https://orcid.org/0000-0001-5518-6138"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},{"id":"https://openalex.org/I4210157844","display_name":"Littlemore Hospital","ror":"https://ror.org/03exj3651","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210157844"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"P. J. Cowen","raw_affiliation_strings":["MRC Unit of Clinical Pharmacology and University Department of Psychiatry, Littlemore Hospital, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MRC Unit of Clinical Pharmacology and University Department of Psychiatry, Littlemore Hospital, Oxford, UK","institution_ids":["https://openalex.org/I40120149","https://openalex.org/I4210157844"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2271,"has_fulltext":false,"cited_by_count":49,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.36974477,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":96},"biblio":{"volume":"9","issue":"3","first_page":"173","last_page":"178"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9096999764442444,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9096999764442444,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10529","display_name":"Stress Responses and Cortisol","score":0.06679999828338623,"subfield":{"id":"https://openalex.org/subfields/2802","display_name":"Behavioral Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.0038999998942017555,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/m-chlorophenylpiperazine","display_name":"m-chlorophenylpiperazine","score":0.9869999885559082},{"id":"https://openalex.org/keywords/anxiety","display_name":"anxiety","score":0.5299999713897705},{"id":"https://openalex.org/keywords/cognitive-performance","display_name":"cognitive performance","score":0.8949999809265137},{"id":"https://openalex.org/keywords/pulse-rate","display_name":"pulse rate","score":0.5590000152587891},{"id":"https://openalex.org/keywords/blood-pressure","display_name":"blood pressure","score":0.8999999761581421},{"id":"https://openalex.org/keywords/acth","display_name":"ACTH","score":0.8180000185966492},{"id":"https://openalex.org/keywords/cortisol","display_name":"cortisol","score":0.9940000176429749},{"id":"https://openalex.org/keywords/prolactin","display_name":"prolactin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/growth-hormone","display_name":"growth hormone","score":1.0},{"id":"https://openalex.org/keywords/mhpg","display_name":"MHPG","score":0.8730000257492065},{"id":"https://openalex.org/keywords/norepinephrine","display_name":"norepinephrine","score":0.7620000243186951},{"id":"https://openalex.org/keywords/alpha2-adrenergic-receptors","display_name":"alpha2-adrenoceptors","score":0.796999990940094},{"id":"https://openalex.org/keywords/serotonin","display_name":"serotonin","score":0.5180000066757202}],"concepts":[{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7428045272827148},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.7392125129699707},{"id":"https://openalex.org/C2779064019","wikidata":"https://www.wikidata.org/wiki/Q66590068","display_name":"Prolactin","level":3,"score":0.6247680187225342},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.6125982403755188},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.5882450342178345},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.5581729412078857},{"id":"https://openalex.org/C2909992730","wikidata":"https://www.wikidata.org/wiki/Q7455050","display_name":"Serotonin Agonist","level":5,"score":0.4731629490852356},{"id":"https://openalex.org/C2776219046","wikidata":"https://www.wikidata.org/wiki/Q162657","display_name":"Neurotransmitter","level":3,"score":0.4596182703971863},{"id":"https://openalex.org/C2778514916","wikidata":"https://www.wikidata.org/wiki/Q186242","display_name":"Norepinephrine","level":3,"score":0.45775023102760315},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.45602554082870483},{"id":"https://openalex.org/C2777477808","wikidata":"https://www.wikidata.org/wiki/Q407595","display_name":"Metabolite","level":2,"score":0.4467766284942627},{"id":"https://openalex.org/C53910766","wikidata":"https://www.wikidata.org/wiki/Q238516","display_name":"5-HT receptor","level":4,"score":0.4188227355480194},{"id":"https://openalex.org/C87813604","wikidata":"https://www.wikidata.org/wiki/Q1242899","display_name":"Crossover study","level":4,"score":0.4165303111076355},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.41554978489875793},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.37240779399871826},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.3511841595172882},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2661236524581909},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000324","descriptor_name":"Adrenocorticotropic Hormone","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000339","descriptor_name":"Affect","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D001007","descriptor_name":"Anxiety","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D001143","descriptor_name":"Arousal","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D001794","descriptor_name":"Blood Pressure","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D003071","descriptor_name":"Cognition","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006339","descriptor_name":"Heart Rate","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D006728","descriptor_name":"Hormones","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006854","descriptor_name":"Hydrocortisone","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D007262","descriptor_name":"Infusions, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008734","descriptor_name":"Methoxyhydroxyphenylglycol","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D010555","descriptor_name":"Personality Inventory","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011388","descriptor_name":"Prolactin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D013006","descriptor_name":"Growth Hormone","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D017366","descriptor_name":"Serotonin Receptor Agonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018592","descriptor_name":"Cross-Over Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/00004850-199409000-00005","doi":"https://doi.org/10.1097/00004850-199409000-00005","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004850-199409000-00005","pdf_url":null,"source":{"id":"https://openalex.org/S149156103","display_name":"International Clinical Psychopharmacology","issn_l":"0268-1315","issn":["0268-1315","1473-5857"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Clinical Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:7814826","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7814826","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International clinical psychopharmacology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2055359652","https://openalex.org/W1982958152","https://openalex.org/W2155624304","https://openalex.org/W2314099240","https://openalex.org/W2210619936","https://openalex.org/W2030642857","https://openalex.org/W2108098421","https://openalex.org/W137622351","https://openalex.org/W70957178","https://openalex.org/W1981443436"],"abstract_inverted_index":{"m-Chlorophenylpiperazine":[0],"(mCPP)":[1],"is":[2,42],"a":[3,18],"metabolite":[4,115],"of":[5,20,46,82,84,93,104,134,141,172,201],"the":[6,47,80,113,132,138,169,196],"antidepressant":[7],"trazodone":[8],"which":[9],"has":[10],"been":[11],"widely":[12],"used":[13],"in":[14,26,72,125,131,137,158,161,168],"psychopharmacology":[15],"research":[16],"as":[17],"probe":[19],"serotonin":[21],"(5-hydroxytryptamine;":[22],"5-HT)":[23],"function.":[24,65],"However,":[25],"addition":[27],"to":[28,37,59,184,206,213],"binding":[29],"at":[30],"5-HT":[31],"receptors":[32],"it":[33,41,193],"also":[34],"binds":[35],"strongly":[36],"alpha":[38],"2-adrenoceptors,":[39],"and":[40,49,98,101,112,136,144,179,198],"conceivable":[43],"that":[44,124,152,195],"some":[45,185],"physical":[48],"psychological":[50,197],"symptoms":[51,92,133],"previously":[52],"reported":[53],"following":[54],"mCPP":[55,85,127,153,202],"infusion":[56,83],"are":[57,203,218],"due":[58,204],"effects":[60,81,200,207],"upon":[61],"central":[62,188],"noradrenergic":[63,189,209],"neurotransmitter":[64],"In":[66,147],"this":[67,215],"double-blind":[68],"placebo-controlled":[69],"balanced-crossover":[70],"study":[71],"12":[73],"healthy":[74],"male":[75],"volunteers":[76],"we":[77,191],"have":[78],"examined":[79],"(0.08":[86],"mg/kg":[87],"over":[88],"2":[89],"min)":[90],"on":[91,208],"anxiety,":[94,135],"cognitive":[95,159],"performance,":[96,160],"pulse":[97,162],"blood":[99,165,177],"pressure,":[100,166],"plasma":[102,139,170,181],"concentrations":[103,140,182],"adrenocorticotrophic":[105],"hormone":[106],"(ACTH),":[107],"cortisol,":[108,142],"prolactin,":[109],"growth":[110,145],"hormone,":[111],"noradrenaline":[114],"3-methoxy-4-hydroxyphenyl":[116],"glycerol":[117],"(MHPG).":[118],"The":[119],"results":[120,150],"confirm":[121],"previous":[122],"findings":[123],"humans":[126],"causes":[128,154],"significant":[129,156],"increases":[130],"prolactin":[143],"hormone.":[146],"addition,":[148],"our":[149],"demonstrate":[151],"no":[155],"changes":[157],"or":[163,167],"systolic":[164,176],"concentration":[171],"MHPG.":[173],"Since":[174],"pulse,":[175],"pressure":[178],"MHPG":[180],"all":[183],"degree":[186],"reflect":[187],"activity,":[190],"believe":[192],"unlikely":[194],"hormonal":[199],"primarily":[205],"neurotransmission.":[210],"Further":[211],"studies":[212],"address":[214],"specific":[216],"issue":[217],"needed,":[219],"however,":[220],"before":[221],"firm":[222],"conclusions":[223],"can":[224],"be":[225],"reached.":[226]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1964396296","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
